Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Inventory (2018 - 2025)

Dna X (SONM) has disclosed Inventory for 8 consecutive years, with $11.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory fell 11.22% year-over-year to $11.0 million, compared with a TTM value of $11.0 million through Sep 2025, down 11.22%, and an annual FY2024 reading of $10.6 million, up 62.97% over the prior year.
  • Inventory was $11.0 million for Q3 2025 at Dna X, up from $9.9 million in the prior quarter.
  • Across five years, Inventory topped out at $12.4 million in Q3 2024 and bottomed at $3.9 million in Q4 2022.
  • Average Inventory over 5 years is $8.3 million, with a median of $9.3 million recorded in 2025.
  • The sharpest move saw Inventory tumbled 58.71% in 2022, then skyrocketed 78.73% in 2025.
  • Year by year, Inventory stood at $5.5 million in 2021, then fell by 29.47% to $3.9 million in 2022, then surged by 66.68% to $6.5 million in 2023, then skyrocketed by 62.97% to $10.6 million in 2024, then increased by 3.44% to $11.0 million in 2025.
  • Business Quant data shows Inventory for SONM at $11.0 million in Q3 2025, $9.9 million in Q2 2025, and $8.6 million in Q1 2025.